Associate Professor, Oregon State University College of Pharmacy
• Advocacy Track: Insights from the field on State Policy, Insurer and Health System Levers to Curb Rx Drug Overdose
Tuesday, March 29, 2016, 11:15 am to 12:30 pm
Dr. Dan Hartung, PharmD, MPH, is an Associate Professor of Pharmacy in the Oregon State University / Oregon Health and Science University College of Pharmacy and an investigator in the Pacific Northwest Evidence-based Practice Center. Dr. Hartung received his PharmD from the University of Wisconsin, MPH with emphasis biostatistics and epidemiology from OHSU, completed a pharmacy residency at the Portland VA Medical Center, and outcomes research fellowship at Oregon State University. Dr. Hartung’s research focus is pharmaceutical health services research, specifically examining how pharmacy benefit structure affects drug utilization and patient outcomes. He is leading a multi-state effort to explore how Medicaid policies involving opioids affect adverse events related to opioid misuse and abuse. He is also PI for an AHRQ-funded project to develop and pilot a Rx drug monitoring program toolkit to help community pharmacists improve the safety of opioid use.